About Fertility Services
Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.
Technavio’s analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Fertility Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Carefertility
• Coopersurgical
• Ferring Pharmaceuticals
• Merck
• MonashIVF
• Vitrolife
Other prominent vendors
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Bristol-Myers Squibb
• Cell Cura
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lilly
• EMD Serono
• Fertility Focus
• Halotech
• HRA Pharma
• IKS International
• In Vitro Care
• Invo Bioscience
• Irvine Scientific
• IVFtech Aps
• Kitazato
• Life Global
• Medical Electronic Systems
• Meditex
• Microtech IVF
• Nidacon International
• Novartis
• NuSep
• Ovascience
• Pantec Biosolutions
• Pfizer
• PregLem
• Reproductive Health Science
• ReproTech
• Sanofi
• Smiths Medical International
• Sperm Processor
• Vitrolife
• Vivus
• Xytex Cryo International.
Market driver
• Increase in infertility rate and obesity
• For a full, detailed list, view our report
Market challenge
• High cost of fertility treatment
• For a full, detailed list, view our report
Market trend
• Increase in R&D
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Infertility: An overview
• Epidemiology
• Signs and symptoms
• Tests and diagnosis
• Treatments
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Stages of fertility treatment
PART 07: Regulatory landscape of ART and IVF
• Reporting requirements
• Regulations governing IVF
• Need for more guidelines and regulations
PART 08: Fertility tourism
PART 09: Cost analysis
• Direct costs
• Indirect costs
• Cost of IVF treatments
PART 10: Market segmentation by type of treatment
• Infertility drugs
• Global infertility drugs market
• ART
• Global ART market
PART 11: Geographical segmentation
• Fertility services market in Americas
• Fertility services market in EMEA
• Fertility services market in APAC
PART 12: Key leading countries
• US
• UK
• Belgium
• China
• India
• Israel
PART 13: Market drivers
• Increase in infertility rate and obesity
• Increase in success rate of infertility treatments
• Growing demand for ART and acceptance of same-sex marriage in developed countries
PART 14: Impact of drivers
PART 15: Market challenges
• High cost of fertility treatments
• Complications related to fertility services
• Ethical, legal, and social issues
• Limited reimbursement
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Increase in R&D
• Establishment of new fertility clinics
• Increase in M&A and collaborations
• Public awareness and government support
• Medical tourism
PART 18: Vendor landscape
• Competitive scenario
• Key news
• Mergers and acquisitions
• Licenses and collaborations
• Key vendor analysis 2015
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
?
Exhibit 01: Product offerings
Exhibit 02: Causes of male infertility
Exhibit 03: Etiologies of female infertility
Exhibit 04: Infertility in people aged 35 and above in US 2002 and 2010
Exhibit 05: Global fertility services market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Stages of fertility treatment
Exhibit 08: Assessment of regulatory landscape
Exhibit 09: Fertility tourism: Major hotspots
Exhibit 10: Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015
Exhibit 11: Average cost of hormonal stimulation in IVF by age ($)
Exhibit 12: Cost analysis of IVF by various stages in US
Exhibit 13: Segmentation of global fertility services market by type of treatment
Exhibit 14: Segmentation of infertility drug usage by geography 2015
Exhibit 15: Global infertility drugs market 2015-2020 ($ billions)
Exhibit 16: Types of ART procedures
Exhibit 17: Segmentation based on adoption of ART procedures in US 2015
Exhibit 18: IVF procedure
Exhibit 19: Success rate of IVF
Exhibit 20: Segmentation based on adoption of ART by geography 2015
Exhibit 21: Global ART market 2015-2020 ($ billions)
Exhibit 22: Segmentation of global fertility services market by geography 2015
Exhibit 23: Fertility services market in Americas 2015-2020 ($ billions)
Exhibit 24: Number of ART cycles in Americas
Exhibit 25: Fertility services market in EMEA 2015-2020 ($ billions)
Exhibit 26: Number of ART cycles in EMEA
Exhibit 27: Fertility services market in APAC 2015-2020 ($ billions)
Exhibit 28: Number of ART cycles in APAC
Exhibit 29: Married women with primary infertility in US 1965-2010
Exhibit 30: Causes of infertility in UK 2009
Exhibit 31: Percentage of infertility among couples attempting pregnancy 2012
Exhibit 32: Population of women of reproductive age (20-44 years) in billions 2015
Exhibit 33: Segmentation of fertility rate among women by age 2014
Exhibit 34: Obesity-related fertility issues
Exhibit 35: Impact of drivers
Exhibit 36: Average cost of various fertility services worldwide
Exhibit 37: Reimbursement scenario in Americas
Exhibit 38: Reimbursement scenario in Europe
Exhibit 39: Reimbursement scenario in Asia
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Number of fertility clinics worldwide 2012
Exhibit 42: Recent M&A
Exhibit 43: Stakeholders involved in fertility services
Exhibit 44: Some trends in global fertility services market
Exhibit 45: CARE Fertility: Key takeaways
Exhibit 46: CooperSurgical: Business segmentation by revenue 2014
Exhibit 47: CooperSurgical: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 48: CooperSurgical: Key takeaways
Exhibit 49: Ferring Pharmaceuticals: Business segmentation
Exhibit 50: Ferring Pharmaceuticals: Key takeaways
Exhibit 51: Monash IVF: Business segmentation by revenue 2015
Exhibit 52: Monash IVF: Geographical segmentation by revenue 2015
Exhibit 53: Monash IVF: Key takeaways
Exhibit 54: Merck: Business segmentation by revenue 2014
Exhibit 55: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 56: Merck: Geographical segmentation by revenue 2014
Exhibit 57: Merck: Key drivers in fertility services sector
Exhibit 58: Merck: Key takeaways
Exhibit 59: Vitrolife: Geographical segmentation by revenue 2014
Exhibit 60: Vitrolife: Key takeaways
Exhibit 61: Drug manufacturing companies
Exhibit 62: Equipment and media developing companies
Exhibit 63: Fertility service providers
